Literature DB >> 10899919

Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling.

M H Baslow1.   

Abstract

N-Acetyl-L-aspartate (NAA) and its derivative N-acetylaspartylglutamate (NAAG) are major osmolytes present in the vertebrate brain. Although they are synthesized primarily in neurons, their function in these cells is unclear. In the brain, these substances undergo intercompartmental cycles in which they are released by neurons in a regulated fashion and are then rapidly hydrolyzed by catabolic enzymes associated with glial cells. Recently, the catabolic enzyme for NAA hydrolysis has been found to be expressed only in oligodendrocytes, and the catabolic enzyme for NAAG expressed only in astrocytes. These results indicate an unusual tricellular metabolic sequence for the synthesis and hydrolysis of NAAG wherein it is synthesized in neurons from NAA and L-glutamate, hydrolyzed to NAA and L-glutamate by astrocytes, and further hydrolyzed to L-aspartate and acetate by oligodendrocytes. Since the discovery that the NAA and NAAG anabolic products of neurons are specifically targeted to oligodendrocytes and astrocytes, respectively, this unique metabolic compartmentalization also suggests that these substances may play an important role in cell-specific glial signaling. In this review, it is hypothesized that a key function of NAA and NAAG in the vertebrate brain is in cell signaling and that these substances are important in the regulation of interactions of brain cells and in the establishment and maintenance of the nervous system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899919     DOI: 10.1046/j.1471-4159.2000.0750453.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  73 in total

1.  Longitudinal whole-brain N-acetylaspartate concentration in healthy adults.

Authors:  D J Rigotti; I I Kirov; B Djavadi; N Perry; J S Babb; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

2.  Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.

Authors:  Alexander P Lin; Frederick Shic; Cathleen Enriquez; Brian D Ross
Journal:  MAGMA       Date:  2003-02       Impact factor: 2.310

3.  Molecular characterization of N-acetylaspartylglutamate synthetase.

Authors:  Ivonne Becker; Julia Lodder; Volkmar Gieselmann; Matthias Eckhardt
Journal:  J Biol Chem       Date:  2010-07-19       Impact factor: 5.157

4.  Expression and localization of myosin-1d in the developing nervous system.

Authors:  Andrew E Benesh; Jonathan T Fleming; Chin Chiang; Bruce D Carter; Matthew J Tyska
Journal:  Brain Res       Date:  2012-01-08       Impact factor: 3.252

5.  Brain MR spectroscopy findings in neonates with hypothyroidism born to mothers living in iodine-deficient areas.

Authors:  A Akinci; K Sarac; S Güngör; I Mungan; O Aydin
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

6.  Dietary triheptanoin rescues oligodendrocyte loss, dysmyelination and motor function in the nur7 mouse model of Canavan disease.

Authors:  Jeremy S Francis; Vladimir Markov; Paola Leone
Journal:  J Inherit Metab Dis       Date:  2013-11-28       Impact factor: 4.982

7.  N-acetylaspartate normalization in bipolar depression after lamotrigine treatment.

Authors:  Paul E Croarkin; M Albert Thomas; John D Port; Joshua M Baruth; Doo-Sup Choi; Osama A Abulseoud; Mark A Frye
Journal:  Bipolar Disord       Date:  2014-12-12       Impact factor: 6.744

8.  Linking mechanistic and behavioral responses to sublethal esfenvalerate exposure in the endangered delta smelt; Hypomesus transpacificus (Fam. Osmeridae).

Authors:  Richard E Connon; Juergen Geist; Janice Pfeiff; Alexander V Loguinov; Leandro S D'Abronzo; Henri Wintz; Christopher D Vulpe; Inge Werner
Journal:  BMC Genomics       Date:  2009-12-15       Impact factor: 3.969

9.  Long-term follow-up after gene therapy for canavan disease.

Authors:  Paola Leone; David Shera; Scott W J McPhee; Jeremy S Francis; Edwin H Kolodny; Larissa T Bilaniuk; Dah-Jyuu Wang; Mitra Assadi; Olga Goldfarb; H Warren Goldman; Andrew Freese; Deborah Young; Matthew J During; R Jude Samulski; Christopher G Janson
Journal:  Sci Transl Med       Date:  2012-12-19       Impact factor: 17.956

10.  Metabonomic characterization of the 3-nitropropionic acid rat model of Huntington's disease.

Authors:  T M Tsang; J N Haselden; E Holmes
Journal:  Neurochem Res       Date:  2009-01-16       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.